Porvoo sarcopenia and nutrition trial: effects of protein supplementation on functional performance in home-dwelling sarcopenic older people - study protocol for a randomized controlled trial

Trials

Reijo S Tilvis²  Harriet U Finne-Soveri¹  Kaisu H Pitkälä³  Merja H Suominen⁴  Mikko P Bjorkman² 

[1] National Institute for Health and Welfare, P.O. Box 30, FI-00271 Helsinki, Finland;Geriatric Unit, Department of Internal Medicine, University of Helsinki, PO Box 340, 00029 HUS Helsinki, Finland;Unit of General Practice, Helsinki University Central Hospital, Department of General Practice, University of Helsinki, PO Box 20, 00014 Helsinki, Finland;Society for Memory Disorders Expertise in Finland, Fredriksberginkatu 2, 00240 Helsinki, Finland

关键词: Randomized controlled trial;    Community-dwelling;    Older people;    Cachexia;    Frailty;    Sarcopenia;   

Others  :  807910
DOI  :  10.1186/1745-6215-14-387

 received in 2013-01-03, accepted in 2013-10-28,  发布年份 2013

【 摘 要 】

Background

Age-related muscle loss (that is, sarcopenia) is a common health problem among older people. Physical exercise and dietary protein have been emphasized in prevention and treatment of sarcopenia. Rigorous trials investigating the effects of protein supplementation on physical performance in sarcopenic populations are still scarce. The aim of this study is to investigate the effects of protein supplementation along with simple home-based exercises on physical performance among home-dwelling sarcopenic older people.

Methods/Design

During 2012 the entire 75 and older population (N = 3,275) living in Porvoo, Finland was contacted via a postal questionnaire. Persons at risk of sarcopenia are screened with hand grip strength and gait speed. Poorly performing persons are further examined by segmental bioimpendance spectroscopy to determine their skeletal muscle index. Sarcopenic patients (target N = 250) will be enrolled in a 12-month randomized controlled trial with three arms: 1) no supplementation, 2) protein supplementation (20 grams twice a day), and 3) isocaloric placebo. All the participants will receive instructions on simple home-based exercises, dietary protein, and vitamin D supplementation (20 μg/d). The recruitment of patients will be completed during 2013. The primary endpoint of the trial is the change in short physical performance battery score and percentage of patients maintaining or improving their physical performance. Secondary endpoints will be, among other things, changes in muscle functions, nutritional status, body composition, cognition, quality of life, use of health care services, falls, and mortality. The assessment times will be 0, 6, 12 and 24 months.

Discussion

To our knowledge, this is the first large scale randomized controlled trial among community dwelling older people with sarcopenia that focuses on the effects of protein supplementation on physical performance.

Trial registration

ACTRN12612001253897, date of registration 28 October 2012, first patient was randomized 11 April 2012.

【 授权许可】

   
2013 Bjorkman et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM, Topinková E, Vandewoude M, Zamboni M: European Working Group on Sarcopenia in Older People: Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010, 39:412-423.
• [2]Rolland Y, Czerwinski S, Abellan Van Kan G, Morley JE, Cesari M, Onder G, Woo J, Baumgartner R, Pillard F, Boirie Y, Chumlea WM, Vellas B: Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives. J Nutr Health Aging 2008, 12:433-450.
• [3]Evans CJ, Chiou CF, Fitzgerald KA, Evans WJ, Ferrell BR, Dale W, Fried LP, Gandra SR, Dennee-Sommers B, Patrick DL: Development of a new patient-reported outcome measure in sarcopenia. J Am Med Dir Assoc 2011, 12:226-233.
• [4]Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, McBurnie MA: Cardiovascular Health Study Collaborative Research Group: Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001, 56:M146-M156.
• [5]Ling CH, de Craen AJ, Slagboom PE, Gunn DA, Stokkel MP, Westendorp RG, Maier AB: Accuracy of direct segmental multi-frequency bioimpedance analysis in the assessment of total body and segmental body composition in middle-aged adult population. Clin Nutr 2011, 30:610-615.
• [6]Björkman MP, Finne-Soveri H, Pilvi TK, Tilvis RS: Bioimpedance spectroscopy as a measure of physical functioning in nursing home residents. Aging Clin Exp Res 2012, 24:612-618.
• [7]Peterson MD, Rhea MR, Sen A, Gordon PM: Resistance exercise for muscular strength in older adults: a meta-analysis. Ageing Res Rev 2010, 9:226-237.
• [8]Milne AC, Potter J, Vivanti A, Avenell A: Protein and energy supplementation in elderly people at risk from malnutrition. Cochrane Database Syst Rev 2009, 2:CD003288.
• [9]Katsanos CS, Chinkes DL, Paddon-Jones D, Zhang XJ, Aarsland A, Wolfe RR: Whey protein ingestion in elderly persons results in greater muscle protein accrual than ingestion of its constituent essential amino acid content. Nutr Res 2008, 28:651-658.
• [10]Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB, Orav JE, Stuck AE, Theiler R, Wong JB, Egli A, Kiel DP, Henschkowski J: Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. BMJ 2009, 339:b3692.
• [11]Paddon-Jones D, Rasmussen BB: Dietary protein recommendations and the prevention of sarcopenia. Curr Opin Clin Nutr Metab Care 2009, 12:86-90.
• [12]Björkman MP, Finne-Soveri H, Tilvis RS: Whey protein supplementation in nursing home residents. A randomized controlled trial. Eur Geriatr Med 2012, 3:161-166.
• [13]Tieland M, van de Rest O, Dirks ML, van der Zwaluw N, Mensink M, van Loon LJ, de Groot LC: Protein supplementation improves physical performance in frail elderly people: a randomized, double-blind, placebo-controlled trial. J Am Med Dir Assoc 2012, 138:720-726.
• [14]Tieland M, Dirks ML, van der Zwaluw N, Verdijk LB, van de Rest O, de Groot LC, van Loon LJ: Protein supplementation increases muscle mass gain during prolonged resistance-type exercise training in frail elderly people: a randomized, double-blind, placebo-controlled trial. J Am Med Dir Assoc 2012, 138:713-719.
• [15]Malafarina V, Uriz-Otano F, Iniesta R, Gil-Guerrero L: Effectiveness of nutritional supplementation on muscle mass in treatment of sarcopenia in old age: a systematic review. J Am Med Dir Assoc 2013, 14:10-17.
• [16]World Medical Association Declaration of Helsinki, Ethical Principles for Medical Research involving human subjects [http://www.wma.net/en/30publications/10policies/b3/index.html webcite]
• [17]Bohannon RW: Hand-grip dynamometry predicts future outcomes in aging adults. J Geriatr Phys Ther 2008, 31:3-10.
• [18]Working Group on Functional Outcome Measures for Clinical Trials: Functional outcomes for clinical trials in frail older persons: time to be moving. J Gerontol A Biol Sci Med Sci 2008, 63:160-164.
• [19]Yamada Y, Schoeller DA, Nakamura E, Morimoto T, Kimura M, Oda S: Extracellular water may mask actual muscle atrophy during aging. J Gerontol A Biol Sci Med Sci 2010, 65:510-516.
• [20]Folstein MF, Folstein SE, McHugh PR: "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975, 12:189-198.
• [21]Guralnik JM, Simonsick EM, Ferrucci L, Glynn RJ, Berkman LF, Blazer DG, Scherr PA, Wallace RB: A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol 1994, 49:M85-M94.
• [22]Nieves JW, Zion M, Pahor M, Bernabei R, Gussekloo J, Simon H, Park JS, Li T, Lapuerta P, Williams GR: Evaluation of continuous summary physical performance scores (CSPPS) in an elderly cohort. Aging Clin Exp Res 2005, 17:193-200.
• [23]Nieves JW, Li T, Zion M, Gussekloo J, Pahor M, Bernabei R, Simon H, Williams GR, Lapuerta P: The clinically meaningful change in physical performance scores in an elderly cohort. Aging Clin Exp Res 2007, 19:484-491.
• [24]Takai Y, Ohta M, Akagi R, Kanehisa H, Kawakami Y, Fukunaga T: Sit-to-stand test to evaluate knee extensor muscle size and strength in the elderly: a novel approach. J Physiol Anthropol 2009, 28:123-128.
• [25]Rikli RE, Jones CJ: Development and validation of criterion-referenced clinically relevant fitness standards for maintaining physical independence in later years. Gerontologist 2013, 53:255-267.
• [26]Guigoz Y, Lauque S, Vellas BJ: Identifying the elderly at risk for malnutrition the mini nutritional assessment. Clin Geriatr Med 2002, 18:737-757.
• [27]Mäkelä J, Laitinen K: [New Index of Diet Quality to support nutritional guidance] Uusi ruokavalion laadun mittari ravitsemusohjauksen tueksi. SLL 2012, 3:161-163. Finnish
• [28]Suominen MH, Kivisto SM, Pitkala KH: The effects of nutrition education on professionals' practice and on the nutrition of aged residents in dementia wards. Eur J Clin Nutr 2007, 61:1226-1232.
• [29]Morris JC, Heyman A, Mohs RC, Hughes JP, van Belle G, Fillenbaum G, Mellits ED, Clark C: The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 1989, 39:1159-1165.
• [30]Welsh K, Butters N, Hughes J, Mohs R, Heyman A: Detection of abnormal memory decline in mild cases of Alzheimer's disease using CERAD neuropsychological measures. Arch Neurol 1991, 48:278-281.
• [31]Sunderland T, Hill JL, Mellow AM, Lawlor BA, Gundersheimer J, Newhouse PA, Grafman JH: Clock drawing in Alzheimer's disease. A novel measure of dementia severity. J Am Geriatr Soc 1989, 37:725-729.
• [32]Hays RD, Sherbourne CD, Mazel RM: The RAND 36-Item Health Survey 1.0. Health Econ 1993, 2:217-227.
• [33]Sintonen H: The 15D instrument of health-related quality of life: properties and applications. Ann Med 2001, 33:328-336.
• [34]Egger M, Jüni P, Bartlett C: CONSORT Group (Consolidated Standards of Reporting of Trials). Value of flow diagrams in reports of randomized controlled trials. JAMA 2001, 285:1996-1999.
• [35]Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL: A new clinical scale for the staging of dementia. Br J Psychiatry 1982, 140:566-572.
• [36]Dunnett CW: A multiple comparison procedure for comparing several treatments with a control. J Am Stat Assoc 1955, 50:1096-1121.
• [37]Juul L, Maindal HT, Zoffmann V, Frydenberg M, Sandbaek A: A cluster randomized pragmatic trial applying Self-determination theory to type 2 diabetes care in general practice. BMC Fam Pract 2011, 12:130. BioMed Central Full Text